1Da Silva CH, Giugliani ER. Consumption of medicines among adolescent students: a concern. J Pediatr(Rio J),2004,80:326-332.
2Komoriya K, Hoshide S, Takeda K, et al. Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia. Nucleosides Nucleotides Nucleic Acids,2004,23:1119-1122.
3Kong LD, Cai Y, Huang WW, et al. Inhibition of xanthine oxidase by ome Chinese medicinal plants used to treat gout. J Ethnopharmacol,2000,73(1-2): 199-207.
4Kong L, Zhou J, Wen Y, et al. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity. Planta Med,2002,68:175-178.
5KongLD, YangC, GeF,etal. AChineseherbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol,2004,93:325-330.
6Mukhin Ⅳ, Ignatenko GA, Nikolenko VY. Dyshormonal disorders in gout: experimental and clinical studies. Bull Exp Biol Med,2002,133:491-493.
7Tausche AK,Richter K, Grassler A,et al.Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option. Ann Rheum Dis, 2004, 63: 1351-1352.
8Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising? J Rheumatol,2002,29:2403-2406.
9Kamienski M. Gout: not just for the rich and famous! Everyman's disease. Orthop Nurs,2003,22:16-20.
10Yu KH, Ho HH, Chen JY, et al. Gout complicated with necrotizing fasciitis report of 15 cases. Rheumatology,2004,13:1-4.
7Wallace SL,Robinson H,Masi AT,et al. Prelimina- ry criteria for the classification of the acute arthri- tis of primary goutIJ]. Arthritis Rheum, 1977,20 (3) : 895 - 900.
8Ma ZS, Qiu MC. Recent development in the risk factors of gout [J]. Geriatr Health Care, 2000, 6 (1):48.
